/NXNN

NXNN Stock - Nexeon MedSystems Inc.

Q: What is the analyst price target for NXNN?

Analyst price target information is not currently available for NXNN.

Q: What is NXNN's market cap?

Market capitalization information is not currently available for NXNN.

Healthcare|Medical - Devices|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Oct 29

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NXNN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2016

FY2017

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta486.97

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2017	FY2016
Revenue	$3.30M	$1.49M
Gross Profit	$-316,691	$818,831
Gross Margin	-9.6%	54.8%
Operating Income	$-6,264,990	$-634,270
Net Income	$-2,177,641	$-802,463
Net Margin	-65.9%	-53.7%
EPS	$-1.23	$-0.59

Company Overview

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

Visit Website

Earnings History & Surprises

NXNN

Beat Rate

67%

Last 3 quarters

Avg Surprise

+81.9%

EPS vs Estimate

Beats / Misses

2/1

Last 12 quarters

Latest EPS

$-0.71

Q4 2018

EPS Surprise History

Q2 18

+290.5%

$0.80vs$-0.42

Q3 18

+47.1%

$-0.37vs$-0.70

Q4 18

-91.9%

$-0.71vs$-0.37

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2019	Apr 5, 2019	—	—	—	—
Q4 2018	Nov 19, 2018	$-0.37	$-0.71	-91.9%	✗ MISS
Q3 2018	Aug 13, 2018	$-0.70	$-0.37	+47.1%	✓ BEAT
Q2 2018	Apr 5, 2018	$-0.42	$0.80	+290.5%	✓ BEAT
Q4 2017	Nov 20, 2017	—	—	—	—
Q3 2017	Aug 11, 2017	—	—	—	—
Q2 2017	May 9, 2017	—	—	—	—

Frequently Asked Questions about NXNN

What is NXNN's current stock price?

Nexeon MedSystems Inc. (NXNN) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for NXNN?

No analyst price targets are currently available for this stock.

What sector is Nexeon MedSystems Inc. in?

Nexeon MedSystems Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.

What is NXNN's market cap?

Nexeon MedSystems Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does NXNN pay dividends?

No, Nexeon MedSystems Inc. does not currently pay a dividend to shareholders.